Global Glucagon Like Peptide1 GLP1 Agonists Market Data Survey Report 2025 [Report Updated: 31102017] Prices from USD $1500
Summary
Glucagon like peptide1 GLP1 agonists is the agonists of the GLP1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global Glucagon Like Peptide1 GLP1 Agonists market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export import
Key manufacturers manufacturing sites, capacity and production, product specifications etc.
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
BristolMyers Squibb
Amylin
Major applications as follows:
Hospital
Pharmacy
Others
Regional market size, production data and export import:
AsiaPacific
North America
Europe
South America
Middle East Africa
Original Article: Global Glucagon Like Peptide1 GLP1 Agonists Market Data Survey Report 2025 [Report Updated: 31102017] Prices from USD $1500
